Minova Life Science

Vizcof Linctus SYP

Bromhexine HCL, Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Guaiphenesin & Menthol | 100ml

Bromhexine HCL

  • A derivate of the Adhatoda vasica plant, enhances the secretion of various mucus components by modifying the physicochemical characteristics of mucus.
  • Common mucolytic cough suppressant in respiratory diseases.
  • Amplifies the actions of the antibiotics when co-administered. 1
  • Early oral administration reduces the ICU transfer, intubation, and mortality rate in patients with COVID-19. 2

Dextromethorphan Hydrobromide

  • A centrally acting non-narcotic antitussive.
  • Has a broad inhibiting efficacy on cough reflex sensitivity. 3

Chlorpheniramine Maleate

  • A potent, less sedative antihistaminic drug, which acts by inhibiting histamine release from mast cells.
  • Known to have anticholinergic properties. 4

Guaiphenesin

  • A mucoactive drug, acts by loosening mucus in the airways and making coughs more productive.
  • Safe and effective expectorant for the treatment of mucus-related symptoms in acute URTIs and stable chronic bronchitis. \
  • Has a well-established and favorable safety and tolerability profile. 5

INDICATIONS

  • Acute bronchitis
  • Chronic bronchitis
  • Chronic obstructive pulmonary diseases
  • COVID-19
Scroll to Top